SLRX - Salarius Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/2016
Total Revenue1,951.3511,851.8922,553.084
Cost of Revenue1,287.6212,129.6723,459.824
Gross Profit663.73-277.78-906.74
Operating Expenses
Research Development---
Selling General and Administrative2,348.3611,471.067817.485
Non Recurring---
Others---
Total Operating Expenses3,635.9823,600.7394,277.309
Operating Income or Loss-1,684.631-1,748.847-1,724.225
Income from Continuing Operations
Total Other Income/Expenses Net14.9941.512500.497
Earnings Before Interest and Taxes-1,684.631-1,748.847-1,724.225
Interest Expense---
Income Before Tax-1,669.637-1,747.335-1,223.728
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-1,669.637-1,747.335-1,223.728
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-1,669.637-1,747.335-1,223.728
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-1,811.65-1,840.109-1,279.399